A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues
出版年份 2017 全文链接
标题
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues
作者
关键词
-
出版物
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 176, Issue 4, Pages 421-430
出版商
Bioscientifica
发表日期
2017-01-19
DOI
10.1530/eje-16-0956
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis
- (2016) Sanne E. Franck et al. NEUROENDOCRINOLOGY
- Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy
- (2015) Pamela Freda et al. Endocrine Practice
- Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3
- (2015) S E Franck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort
- (2015) Caroline Sievers et al. Pituitary
- Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
- (2014) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegaly
- (2013) Michael Madsen et al. CLINICAL ENDOCRINOLOGY
- A Comprehensive Study of Clinical, Biochemical, Radiological, Vascular, Cardiac, and Sleep Parameters in an Unselected Cohort of Patients With Acromegaly Undergoing Presurgical Somatostatin Receptor Ligand Therapy
- (2013) Anand K. Annamalai et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
- (2013) Philippe J. Caron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes
- (2013) Antonio Bianchi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Evaluation of growth hormone (GH) action in mice: Discovery of GH receptor antagonists and clinical indications
- (2013) John J. Kopchick et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly
- (2012) Patrick Petrossians et al. ANNALES D ENDOCRINOLOGIE
- Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study
- (2011) M. Filopanti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone
- (2010) Aart-Jan van der Lely et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly
- (2009) Peter J. Trainer et al. CLINICAL ENDOCRINOLOGY
- Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients
- (2009) SJCMM Neggers et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pituitary-independent effect of octreotide on IGF1 generation
- (2009) Ana Pokrajac et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
- (2009) Mónica Marazuela et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- ACROSTUDY: the first 5 years
- (2009) Peter J Trainer EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
- (2009) Ignacio Bernabeu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly
- (2008) Antonio Bianchi et al. Pituitary
- Wide variation in surgical outcomes for acromegaly in the UK
- (2007) P. R. Bates et al. CLINICAL ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now